Dr Liu on the Benefits of Biomarker Testing in NSCLC

Stephen V. Liu, MD, discusses the benefits of conducting biomarker testing for patients with advanced non–small cell lung cancer and highlights the importance of waiting for the results before selecting a targeted treatment.

Related Keywords

Stephenv Liu , ,Georgetown University ,Georgetown Lombardi Comprehensive Cancer Center ,Thoracic Oncology ,Developmental Therapeutics ,Per New York Lung Cancer Symposium ,News ,Lung Cancer ,Conference ,